Oppenheimer Asset Management Inc. Grows Position in Intuitive Surgical, Inc. $ISRG

Oppenheimer Asset Management Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 53,308 shares of the medical equipment provider’s stock after buying an additional 610 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Intuitive Surgical were worth $28,968,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Norway Savings Bank raised its holdings in shares of Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares in the last quarter. IronOak Wealth LLC. purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $1,099,000. Trust Co. of Oklahoma purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $363,000. Neville Rodie & Shaw Inc. raised its holdings in shares of Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after buying an additional 1,110 shares in the last quarter. Finally, Sax Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 218.1% during the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after buying an additional 1,684 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.9%

Intuitive Surgical stock opened at $546.51 on Friday. The business’s fifty day simple moving average is $458.09 and its two-hundred day simple moving average is $497.29. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the company posted $1.84 earnings per share. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ISRG. The Goldman Sachs Group decreased their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Wednesday. Piper Sandler lifted their price target on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research note on Wednesday. Finally, Evercore ISI decreased their price target on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $602.32.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.